A lead-in dose of NVP 200 mg once daily should be
given for the first 14 days in new adult patients on NVP. If no
rash is observed, increase dose to twice daily. Take normal dose
of the other two ARVs in the regimen in those first 14 days.
Switch to the triple Fixed Dose Combination (FDC) tablet after 14
days if applicable.
HIV infection, alternative first line treatment (in combination
with TDF + 3TC)
Adult and child >25 kg: 200 mg every 12 hours
(lead-in dose 200 mg once daily for 14 days)
Child <25 kg: Use NVP 50 mg tablet as in
table below
| Weight (kg) |
No. of NVP 50 mg tablets |
| 20–24.9 |
3 tabs every 12 hours |
| 14–19.9 |
2½ tabs every 12 hours |
| 10–13.9 |
2 tabs every 12 hours |
| 6–9.9 |
1½ tabs every 12 hours |
| 3–5.9 |
1 tabs every 12 hours |
HIV infection, first line treatment in children (in combination
with ABC + 3TC)
Child <3 years: 4 mg/kg twice daily
(lead-in dose 4 mg/kg once daily for first 14 days)
eMTCT infant regimen (0–6 weeks)
Infant 2–2.49 kg: 10 mg once daily for 6
weeks
Infant ≥2.5 kg: 15 mg once daily for 6 weeks